Initial clinical experience using the Gianturco-Grifka vascular occlusion device for congenital heart defects  by Grifka, Ronald G. et al.
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patients had moderato reje~un (grade 3a or 3b), the remainder were grade 
0 to lb. All HTR patients had myocardial relaxation velocities detsrmined 
by PWDTI pdor to, dudng, and following successful treatment from HTR at 
the time of EB, PEV were measured from the short axis view of the infere- 
postedor wall by PWDTI (Acucon XPot28), Results: There was a significant 
reduction in PEV dudng HTR from 0,196 :E 0,021 to 0,120 d: 0,029 m/sac,; 
p < 0,0001 with subsequent normalization following successful trea~nest to 
0.184 :~ 0,036 rn/sec, p < 0.0001 (see graph). Furthermore, a PEV of >0.15 
nYs has a negative predictive value of 95% to exclude rejection, a sanS~ 
of 92% and specificity of 60%. 
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Conolusion: HTR resulP, in a reduction in myocardial peak eady relaxation 
velocities. Hence, PWDTI may be a clinically useful noninvasive tool for the 
diagnosis of HTR and for following responses to therapy. 
~ N e o d  for Close Monitoring of Moderate Cardiac 
AIIograft Rejection ISHT 2 
Hans R Brunnsr-La Rocca, Gabor Suetsch, Jakob Schneider, 
Ferenc Follath, Wcifgang Kiowski. University Hospital, Cardiology, Zurich, 
Switzerland 
The natural course of rejection ISHT 2 is poody defined and the need for and 
interval between follow-up endon,~yocardial biopsies (EMB) am nor clear, 
Thsrefore, we analysed all EMB (n = 2868) from 161 transplant patients 
(mean age 47.7 :E 12.2 years, 148 mal~) on triple drug immunusuppressico 
since the introdu~on of the ISHT-ncmanciature at our institute. EMB were 
performed from day 3 up to 8,9 years after lransplantation (tx; median 197 
days). 374 episodes with ISHT 2 rejection were detected and had a fcilow- 
up EMB 7 to 10 days later without Change Of immunosuppression. ISHT 2 
rejection progressed (ISHT > 3A) in 67 (19.0%), persisted (ISHT 2) in 78 
(22.1%) and regressed (ISHT _< IB) in 208 rases (58.9%). In comparison, 
1884 scheduled EMB which were not follow-up EMB showed ISHT ~> 3A in 
145 (7,7%), ISHT 2 in 224 (11,9%) and ISHT .< 1B in 1515 (80.4%) cases (p < 
0.0001 ). The odds ratio (OR) for rejection ISHT >_ 3A 7 to 10 days after ISHT 
2 rejection was 2,81. This was highest at month 2 after tx (OR = 6.43, p < 
0.0001 ), lowest at month 5 (OR = 1,43, n.s,) and remained elevated latsr than 
one year after tx (OR = 3.88, p < 0,0001). Multivariate logistic regression 
analysis including most known risk factors for graft rejection showed that 
ISHT 2 rejection on previous EMB independently predicted rejection ISHT > 
3A and remained the most important dsk factor for rejection ISHT _> 3A (OR 
= 2,40, p < 0,0001) even late (> 1 year) after Ix (OR ,, 3.55, p = 0.001). 
Conclusion: These findings suggest hat moderate rejection ISHT 2 pro- 
gresses to higher grade of rejection in a considerable number of patients and 
close monitoflng :.,,alns necessary even late after tx, 
~ Non.lnvoslve Detection of Cardiac AIIograft 
Rejection bY Multiva_rlate Analys!s of Computer 
Qenemtad M-Moae oata In Pediatric Pat!onto 
Andrew J, Maxwell, Daniel Bemalain. Stanford University, Stanford, CA 
The aim of this study was to determine ifa computer program, dP"-'~ed to 
analyze echo~rdiographic M-Modes, could predict allogreft rejectloi~. Seflal 
echocardiograms (n= 7~,) were pelfermed in 5 patients, each within 24 hours 
of RV endomyocardlal biopsy. M-Modes wefe digltalized and retrospectivaly 
analyzed by a computer program designed to curve-tit he inner and outer 
posterior wall and both edgas of the ssptum averaged over 4 tO 7 cardiac 
cycles, Manipulation of the equations describing these curves produced 47 
data values of distances, volumes, rates of change and time pefinds from 
each M-Mode analysis. The collective datum were analysed for osrraiation 
with btupsy results (no evidence of rejection (N), ISHLT grades I and II (M), 
grades III and IV (S)) after conversion to individual Z scores. D~Ja was 
subjected to Hierarchical Discdminata Fun~ico Analysis (HDFA) designed 
to minimize Wilks' Lamlxla. HDFA produces a set of classification equations 
which assigns cases to rejection groups and additionally preduce~ a Csntreid 
Mop giving visual information on the reliability of any one assignment, HDFA 
resulted in several combinations of vadables and cosfficien~ producing 
sfgniticance (p < 0.001) between the three rejection groups. Cross-validation 
resulted in a sensitivity to defect aPy rejection of 0.89, to detect M of 0,74, 
and to detect S of 0.78 (specificity = 0.86). The positive predictive value for 
M = 41% ~,nd S = 64%. Misessigned cases plotted on the Centmid Map in 
locations uspicious for reliability. 
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We conclude this program, in conjunction with HDFA, is useful in predicting 
mild and severe rejection. 
~ Protective Effects of Complement Blockade In an 
Isograft Model of Lung Preservation and 
Transplantation 
Yoshitumi Naka, Dilip K. Roy, Henry C. Marsh t, Susanne M. Scosney ~, 
Una S. Ryan, David M. Stem, Hui Liao, Robert E. Michler, Mehmet C. Oz, 
David J. Piasky. Columbia University, New York, NY; 1 T Cell Sciences, 
Needham, MA 
Agents which inhibit complement activation protect against myocardial repot- 
fusion injun/and may be beneficial in xenotranaplantalJon, but it is not known 
whether complement activation is deletadous following lung preservation 
and transplantation i an isograft model. Lungs harvested from Lewis rata 
subjected to 4 ¢ C 6 hour preservation in Euro-Collins solution followed by 
transplantation i to Lewis recipiel~ts demonstrated increased immunostaln- 
Ing for C5b-9 cOmpared with nontransplanted controls, confirming local com- 
plement activation in this model. To inveStigate the physiologic relevance of 
complement a~vation in the trans;~lanted lung, the native pulmonary artery 
(PA) was ligated following transplanta~o~, and pulmonary vascular resis. 
tance (PVR, mm Hg/ml/mln), PA flow (PAl=, ml/mln), artedal oxygenation 
(.o02, mm Hg), graft neutrephil nfiltration (myeloparexJdese act~ty, MPO, 
~Abs 460 nnVmin), and recipient survival (Surv, %) were measured at 30 
minutes. Animals received either saline (control; n = 12) or soluble comple- 
ment receptor typ~-I (sCRt, 15 ms/ks, serum level range 127-355 p.g/ml by 
ELISA; n ,= 9) 2 minutes pdor to reperfusion, sCR1 treated animals showed 
a marked reduction in serum complement activity (CHS0 90% lower than 
control animals, p < 0.gg01). 
PVR PAF pO2 MPO SuP/ 
Control 8.5.4-1.5 4.94- 2.8 1254- 38 3.2:1:0.2 23% 
sCR1 2.9:1:1.1" 17.4i3.4" 1944-34 2,1 4-0.21" 74%t 
'~ p < O,05;l"p < 0,005 
In parallel with the reduction in CH50 in sCRI treated animals, Immunohis- 
tology revealed decreased C5b-9 deposition conlpared with confi'ols. Taken 
together, these data indicate that local complement activation occurs fol- 
lowing lung preservation and Imnaplantatlon i  an isograft model, and that 
inhibiting complement improves outcome to[lowing transplantation. 
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~ Snare-Asslstod Delivery for Transcathotar Coil 
Occlusion of Ductus Arteriosus 
Robert J. Sommer, Frank F. In(]. Mount Sinai Medical Center, New York, IVY 
Schneider Children's Hospital, New York, N~ Texas Children's Hospital, 
Houston, TX 
Transartedal and transvenous techniques for transcatheter occlusion of small 
patent ductus arteriosus (PDA) u:;ing a Gtanturco coil (GC) have been com- 
plicated by GC embolization to the pulmonary and systemic /rcutation, by 
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failure to implant the coil, and by incomplete closure. We report a snare- 
assisted technique wh~l optimizes 0oil position for improved occlusion and 
minimizes dsk of embollzation. 
Mgthods:94 ptS (9.3-70.2 ym, median 3,3 yrs) underwent PDA occlusion 
using a snare-assisted approach. Minimum PDA diameter was 0,6--7.0 mm 
(median 2.3 ram), The snare was advanced to the main pulmonary artew 
(MPA) via the femoral vein to hold and manipulate the GC as it was delivered 
from the coil delivery catheter advanced across the PDA from the asrtio 
side. 1/4 loop of GC was inittally "sn~czed" on the MPA side of the PDA. With 
traction on the snare, the remaining coil IoOl~ were delivsrad to the aortic 
side. GC was then positioned optimally with the snare by pulling additional 
loop(s) to the MPA side and wedging them into the aodio ampulla. Prior to 
release, traction on the snore tested stability of GC posit}on, 
Results: GC placement was successful in 94/94 pts (100%) wi~ docu- 
mented complete closure in 86/94 (91A%). Immediate closure was observed 
in 75 by angingraphy and in 11 by echocardingraphy within 24 hours follow- 
ing coil implant. A single GC was used in 83/94 (88%) while 2-4 GCs were 
used in 11 patients. Snare was used to remove 1-6 GCs in 26/94 pts prior 
to snare release due to: GC slipping through PDA to MPA wi~ traction (5), 
LPA impingement (5), coil protrusion into aor~c lumen (4), other suboptimal 
cog position (9), inability to free coil from snare (3). In 3/94 (3.3%) pts, GC 
embotizocl to PA, but was retrieved in cath lab with sul0SeCluent successful 
duutal closure. There were no systemic embOlizations. 
Conclusion: The snere-ossisted elivery technique impmvas conb'ol of the 
GC ~ accuracy of its dalivety/placemenL 
~ Initial Clinical Experience Using the 
Gianturce-Griflm Vascular Occlusion Device for  
Congenital Heart Deles'to 
Ronald G. Gdfka, Chades E. Mu[lins, Julie A. Vincent, William S. McMahon, 
Michael R. Nihill, Frank RIng, Martin R O'Laughlin, Larry A. ~tsen, John 
W. Moore, W. Robed Monow, Cesam Giantumo. Texas Children's Hospital, 
Houston, Texas 
Several devices have been developad for transcatheter vascular oc,'Jusion. 
These devices have limitations including inability tO adjust device posit}on, 
embolizaifon, and residual eaks. Wdh efforts to overcome these limitations, 
we report the first implants using the Gianturoo-Grifka Vascutsr occlusion 
device (GGVOD). The GGVOD consists of a nylon sack attached to an 
end-hole catheter; a filler wire is inserted through the catheter into the sack. 
In 8 lOtS, 10 vesSels were occluded using the GGVOD. Age ranged hem 2 
me to 35 yr (median 5.5 yr), weight ranged from 4.5 to 93 kg (median 21 kg). 
VeSsel diameter ranged from 4.3 to 6.2 rare (mean 5.3 ram). The GGVOD 
size chosen was 0.5-1.3 mm larger than the vesSel diamater. The vessels 
occluded were: Ao-PA collateral (3), PDA (2), SVC (2), intr~ulmena~y AVM 
(2), intracardiac i~ffle leak (1). fn 4 of 8 10is, prior to device release, the 
GC~VOD was ropositioned to a preferable location. In all vessels, the GGVOD 
was implanted without prebleros, resulting in complete o¢¢tssion. There were 
no device embotiZationa. 
In 2 pts with large vessels (9.2 mm azygous vein, 9.4 mm AVM), a 9 rare 
GGVOD was used to partially occlude the vessels, erKI to serve as a base 
upon which embolization coils were implanted. Both vessels were occluded 
completely. 
All pte had follow-up clinic evaluations 1 to 6 me post-GGVOD implant. 
There have been no late device embelizations or residual leaks, The PDA and 
Ao-PA collateral pts have decreased cardiomegaly and improved exercise 
teterance, 
Conclusion: The GGVOD can be ropositioned prior to release, affording 
safe and effective transsathater occlusion of tubular PDA, Ao-PA coifatereJ, 
AVM, SVC, and other vassals. 
~ Medium Term FOllow Up After Tninscatheter 
Umbrella Closure of  Perlmembmneaua Ventdoular 
Septal Defect p/SO) 
M,L. Rigby, M. Heinsdijk, A.N. Redington, M. Vogel, IE. Horewitz, Royal 
Bmmpton Hospital, LONDON, UK 
From Oct 91-Sept 94, 17 infants and children underwent attempted tran- 
scalheter umbrella closure of a pedmerobraneous VSD, The procedure was 
unsuccess~l in 3 because the defect was too large. 2 patients required 
surgery, due to malposition (1) and severe aortic regurgitation (1) after 6 
months. 1 late death was unmtsted to the VSD closure. 10 of 11 remain- 
ing patients have undergone investigation to assess outcome 1 to 4 years 
(mean 1.6) later. On the electrocardiogram 6 have complefe (3) or partial 
(3) right bundle branch block. On 48 hour Holtsr all patients remain In si- 
nus rhythm without premature beats or taChysardla. With llanefhoroclc and 
transaesophagaal echooardiogrephy 4 patients had complete occlusion ef 
tl~ defect. The remaining 6 have small residual detects only. Mild and In- 
sigrdflcant ricuspid regurgitation was found In 4, The Doppler dedved right 
ventdculer systolic pressure from the VSD or tricuspid regurgitant velocity 
profiles waS 24-36 (mean 30 mmHg). Although none had evidence of left 
ventrioutar outflow tract obsfruclJon or aortic incompetence, apposition of 
the right coronary anrti¢ valve leaflet and the distal umbrella was evident 
in 4. At cardiac cathatedsation, small residual defects were confirmed in 6 
patients (mean QP:QS 1.9:1; mean pulmonary arterial systolic pressure 28 
mmHg), in conclusion. 1--4 years following umbrella closure of perimem- 
bransous VSD all patients are symptom free, right bundle branch block is 
frequestiy observed and a small residual VSD is present in more than half. 
Some patients appeared to have the potential to develop aortic regurgitation 
or aubaodio atanasis because of the position of the distal umbrella in the 
left venfricular outflow tract. Umbrella closure of a podmembmneous VSD 
cannot be recommended as a routine procedure. 
~ Init~l Results of  the US. PFO/ASD Closure "rrlal 
Glao'win S. Oas 1, Z'pjad M. Hijazi, Martin P. O'Laughlin, ~(an 
M. Mendelsohn, for the Investigators. I University of Minnesota, 
Minneapolis, MN 
In the USA, 24 patients have undergone closures with the Das ~" Angel 
Wings TM Imnssathater ASD closure device. (Secundum ASDs in 17, PFOs 
with presumed paradoxical cerebral embolism in 6, and 1 with residual 
shunting following ASD closure with the Clamshell" device). The patients 
were 21 ± 173 (mean =E SD) years old (range 3 to 75 yrs.) and. weighed 
56.1 :b 25.2 Kg. (range 14 to 111 Kg). The echaoerdiographic diameter 
of the defects was 9.0 :I: 5.7 ram. All patients with secundum ASDs had 
ech0cardiogrephic evidence of RV dilation and paradoxical motion of the 
IVS, 
ReJ;ults: N124 p~ents had a device successfully deployed. In 23 patients 
device waS deployed in the first attempt and in 1 patient a device deployed 
entirely into the LA was retrieved, followed by a seesnd successful closure. 
The balloon occlusive diameter leD), (minimum diameter of the balloon that 
could not be pulled through the defect), was 15,2 ~: 3.6 mm (range 10 to 
23 ram). The device (D) size used was 23.3 ± 3.6 mm (range 18 to 35 
mm). The D:OD ratio was 1.58 ± 0.24 (range 1.1 to 2.0). In 3 patients either 
the LA (n = 1) or P,A (n = 2) disk did hot open fully due to a large device 
size or suboptimal deployment. Transthoracic echocerdiography 24 hours 
later shm'~ad no shunting in 18, trivial (< 1 mm) in 3, small (1---2 ram) in 
1, moderato (3 ram) in 1, and large (>4 ram) in 1. Presence of residual 
small to large shunts was related to suboptimal deployment of the LA disk 
(n = 1) or a D:OD ratio <1.2 (n = 2). None of the devices embelized. There 
were no procedural complications. Conclusions: These results suggest hat 
trans,',athater closure of PFOs and ASDs with this new device is feasible and 
safe. 
~ Traoscetheler Closure of Secundum Atrial Septal 
Defects With the ASDOS Device in Chi ldren 
M. Schneider, U. Babio, B. F~ch,  G, Hausdorf. Char/~, Humboldt 
Universe, Berlin, Germany 
We report our in~al experence with the ~etar  occlusion of atdal sop- 
tat defects (ASD) in 15 children (body weight 12 to 42 kg) using the ASDOS 
device (Dr, Ing. Osy~a Coq~. Germany). The ASDOS device Consists of 
two umbrellas with a central body and rnte arms made out of nitinol, covered 
by a thin polyu~thaee patch. Both umbrellas am connected by screwing 
a Hit at the distal umbrella into ~e thrast of the proximal. Balloon sizing 
under transthora~ and tmnsesophagaal echocerdingrephio guidance was 
performed to measme the "slretched" diameter of the defect and a device 
witch deublad the size Of the defect was selected fur implantation, 
The "stre~eo" diameters of the defect ranged from 10 to 20 ram, the 
pufmOnic:-~syatemic bleed flow ratio from 1.5: ~. to 2.8:1. Trauscetheler ctO- 
sure was successhJily perlormed in 15 paflants using devices with a diameter 
ef~to4Omm. 
No significant complications were obasrvad udng this Inittal al~lications, 
During the follow~up aded of 2 to B months no dev~.ce mbolisations, throm- 
bcorobelio complisationL% abial padorations, paficardial effusions, atriovan- 
•cular valve dysfunctions or other complications occurred. Min{mal residual 
shunting (< 3 mm diameter) was observed in 3/15 patients. 
Desp~e our limited expadence and ~ow-op pe~od it can be concluded 
that this new device is a promising ~eter  approach for the osclusion 
of ASD's in children. 
~ Repeat Bal loon Aortic Valvuloplasty: Is It 
Worthwhile? 
David Shim, Thomas R. Lloyd, Robert H. Beekman IlL Division #pediatric 
Cat~l/otogy, G.S. Molt Cht7dmn's Hospital University of Michigan, Ann Arbor, 
Ul 
Restanosis has been obsewed following balloon aortic valvuioplasty (BAV), 
